Healthcare Professionals
Please log in for special information and services

Product Details

BESREMi® is indicated as monotherapy in adults for the treatment of Polycythaemia Vera without symptomatic splenomegaly.

BESREMi® 250 micrograms/0.5 mL solution for injection in pre-filled pen 

Patient Information Leaflet BESREMi® in German

Drug Facts 

Active Ingredient:

Ropeginterferon alfa-2b